Cancer Cancer
Conditions
Interventions
This feasibility study takes the form of a cluster randomised controlled trial. Participants will be adult patients consulting with a primary care practitioner about non-specific symptoms that could b
adult family members or informal carers who accompany eligible patients in consultations
and staff in participating surgeries with a safety-netting role (clinical, management/administrative).
Work package 1 (months 1–6): We will work with six GP surgeries in Bradford, Airedale, Wharfedal
Sponsors
Bradford Teaching Hospitals NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Patient/carer inclusion criteria for intervention: 1. Patients aged 18 and over presenting with non-specific symptoms which could indicate cancer, who have capacity to decide on their own medical treatment. 2. Patients aged 18 and over presenting with non-specific symptoms which could indicate cancer, who do not have capacity to decide on their own medical treatment, but who are accompanied in the consultation by a family member or informal carer (consultee). 3. Family members or informal carers aged 18 and over who accompany SSNAP-coded patients in consultations. Patient/carer inclusion criteria for questionnaires: 1. Patients aged 18 or over in intervention surgeries who have received SSNAP or who were recorded as eligible to receive SSNAP in control surgeries. 2. Family members/informal carers aged 18 and over who accompany patients in consultations where SSNAP was used in intervention surgeries or where the patient was recorded as eligible to receive SSNAP in control surgeries. Patient/carer inclusion criteria for interviews: 1. Patients aged 18 or over in intervention surgeries who have received SSNAP. 2. Family members/informal carers aged 18 and over whose relative/significant other has received SSNAP in an intervention surgery. Staff inclusion criteria (intervention, interviews, focus groups) 1. All staff in participating surgeries with a safety-netting role (clinical, management/ administrative).
Exclusion criteria
Exclusion criteria: Patients/carer exclusion criteria for intervention: 1. Young people and children aged under 18 years. 2. Patients aged 18 and over who do not have capacity to consent to their own medical treatment and who either are not accompanied by a family member or informal carer (consultee), or the consultee does not agree to receiving the SSNAP plan. 3. Patients who have opted out of data sharing. Patient/carer exclusion criteria for questionnaires & interviews: 1. Patients who meet the inclusion criterion but for whom participation in questionnaires or interviews could cause distress or confusion, including patients without capacity to consent to the research or patients who are too ill to participate (e.g. at the end of life). 2. Patients, family members/informal carers aged less than 18 years. 3. Family members/informal carers of patients who received SSNAP (in intervention surgeries) or were recorded as eligible to receive SSNAP (in control surgeries) but passed away before the invitation to complete a questionnaire is circulated, so as not to cause unnecessary distress. Staff exclusion criteria: 1. Staff not involved in safety-netting processes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnosis of cancer at any stage is measured using anonymised electronic health record data from SystmOne at the end of WP1 (months 5-6 of the study) and in WP3 (months 16-17) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time to re-attend, anonymised data will be collected twice from SystmOne: at the end of WP1 (months 5–6 of the study) and in WP3 (months 16–17) 2. Referral(s) for follow-up diagnostic tests, anonymised data will be collected twice from SystmOne: at the end of WP1 (months 5–6 of the study) and in WP3 (months 16–17) 3. Number of re-attendances & DNAs over intervention period, anonymised data will be collected twice from SystmOne: at the end of WP1 (months 5–6 of the study) and in WP3 (months 16–17) 4. Number of patients re-booking appointments, anonymised data will be collected twice from SystmOne: at the end of WP1 (months 5–6 of the study) and in WP3 (months 16–17) 5. Number of occasions intervention used (intervention surgeries) or would be used (control surgeries), anonymised data will be collected twice from SystmOne: at the end of WP1 (months 5–6 of the study) and in WP3 (months 16–17) 6. Willingness of surgeries to be randomised, data collected during interviews and focus groups with participating staff during WP3 (months 16 and 17 of the study) 7. Willingness of staff to initiate SSNAP with patients, data collected during interviews and focus groups with participating staff during WP3 (months 16 and 17 of the study) 8. Number of interviews/ focus groups/questionnaires completed, to be determined when these have taken place, around month 21 9. Intervention patients’/families’ perspectives on SSNAP feasibility & acceptability, collected in patient/carer questionnaires and interviews during WP2 and WP3 (months 8–17 of the study) 10. Consultation satisfaction for intervention & control patients/families, collected in patient/carer questionnaires and interviews during WP2 and WP3 (months 8–17 of the study) 11. Number of eligible patients, anonymised data will be collected twice from SystmOne: at the end of WP1 (months 5–6 of the study) and in WP3 (months 16–17) 12. Number of patients followed-up, anonymised data will be collected twice from SystmOne: at | — |
Countries
England, United Kingdom
Contacts
Public ContactLynn McVey
Outcome results
None listed